Growth stimulation of non-small cell lung cancer xenografts by granulocyte-macrophage colony-stimulating factor (GM-CSF)

By Oshika Y.   Nakamura M.   Abe Y.   Fukuchi Y.   Yoshimura M.   Itoh M.   Ohnishi Y.   Tokunaga T.   Fukushima Y.   Hatanaka H.   Kijima H.   Yamazaki H.   Tamaoki N.   Ueyama Y.  

European Journal of Cancer, Vol. 34, Iss. 12, 1998-11 ,pp. : 1958-1961

Elsevier

Access to resources Recommend Favorite

Local application of granulocyte-macrophage colony stimulating factor (GM-CSF) for the treatment of oral mucositis

By Sprinzl G.M.   Galvan O.   de Vries A.   Ulmer H.   Gunkel A.R.   Lukas P.   Thumfart W.F.  

European Journal of Cancer, Vol. 37, Iss. 16, 2001-11 ,pp. : 2003-2009

Elsevier

Access to resources Recommend Favorite

Phase I Trial of Etoposide, Doxorubicin and Cisplatin (EAP) in Combination with GM-CSF

By Ford P.A.   Arbuck S.G.   Minniti C.   Miller L.L.   DeMaria D.   O'Dwyer P.J.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 631-635

Elsevier

Access to resources Recommend Favorite

Phase trial of granulocyte-macrophage colony-stimulating factor plus thalidomide in older patients with castration-resistant prostate cancer

By      

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 865-868

Science Publishers

Access to resources Recommend Favorite

Properties of bcr-abl-transformed mouse 12B1 cells secreting interleukin-2 and granulocyte-macrophage colony stimulating factor (GM-CSF): II. Adverse effects of GM-CSF

By          

International Journal of Oncology, Vol. 40, Iss. 6, 2012-01 ,pp. : 1915-1922

Spandidos Publications

Access to resources Recommend Favorite